Nurse Practitioner in Quincy, WA Accepting Medicare
4 Nurse Practitioner nurses found. Showing 1 - 4
 Robin Trost, ARNP, FNP-BC Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 908 10th Ave Sw, Quincy, WA 98848 Phone: 509-787-3503 Fax: 509-787-1361 |
 Justin Stoltzfus, NP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1450 1st Ave Sw, Quincy, WA 98848 Phone: 509-787-6423 |
Mrs. Rachel Erin Gaspard, FNP-BC Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1450 1st Ave Sw, Quincy, WA 98848 Phone: 509-787-6423 Fax: 509-764-0344 |
Mark Sherberg, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1450 1st Ave Sw, Quincy, WA 98848 Phone: 589-787-6423 |
News Archive
The Ensign Group procures $35 million seven-year term loan from RBS Asset Finance
The Ensign Group, the parent company of the Ensign group of skilled nursing, rehabilitative care services, hospice care and assisted living companies, announced that a group of its real estate holding subsidiaries has procured a US$35 million seven-year term loan from RBS Asset Finance, Inc., an affiliate of The Royal Bank of Scotland Group.
Time for a switch for patients with rheumatoid arthritis and ankylosing spondylitis
The comparable safety and efficacy of switching patients to a biosimilar anti-TNF-α monoclonal antibody from the reference medicinal product (RMP) has been further established in data presented at EULAR 2015, the annual meeting of the European League Against Rheumatism.
Cappella commences evaluation of the Sideguard Coronary Sidebranch Stent & Delivery System
Cappella, Inc., a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, announced the start of Sideguard 3, an IVUS/OCT evaluation of the Sideguard® Coronary Sidebranch Stent & Delivery System. This is a European multicenter study to evaluate the vascular response to Sideguard in de novo bifurcation lesions of native coronary arteries.
Obj-SCD predicts future amyloid accumulation and neurodegeneration
Writing in the December 30, 2019 online issue of Neurology, researchers at University of California San Diego School of Medicine and Veterans Affairs San Diego Healthcare System report that accumulating amyloid - an abnormal protein linked to neurodegenerative conditions such as Alzheimer's disease - occurred faster among persons deemed to have "objectively-defined subtle cognitive difficulties" (Obj-SCD) than among persons considered to be "cognitively normal."
› Verified 1 days ago